FolioMetrix’s Biogen BIIB Stock Holding History

FolioMetrix’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$1.3M	Buy	3,100 +1,224	+65%	+$491K	0.55%	37
2015 Q1	$791K	Buy	1,876 +959	+105%	+$378K	0.4%	56
2014 Q4	$316K	Buy	+917	New	+$297K	0.22%	95

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FolioMetrix's BIIB Position: Q2 2015 in Review

FolioMetrix increased its Biogen (BIIB) stake by 65% in Q2 2015, buying an estimated $491K and bringing the position to 3,100 shares worth $1.3M. The position accounts for 0.55% of the portfolio, ranked #37.

FolioMetrix first reported a position in BIIB in Q4 2014 and has held it in 3 quarters since. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

FolioMetrix held 3,100 shares of Biogen worth $1.3M as of Q2 2015.
FolioMetrix bought 1,224 Biogen shares in Q2 2015, an estimated $491K.
Biogen made up 0.55% of FolioMetrix's portfolio in Q2 2015, its #37 holding.
FolioMetrix first reported a position in Biogen in Q4 2014 and has held it in 3 quarters since.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.